Company Profile
Novo Holdings is a Danish private investment company focused on life sciences. With over 1,500 employees in offices around the world, including Copenhagen, Boston, San Francisco, London, and Hong Kong, the organization is one of the largest life science investors globally. Established in 2010 as a subsidiary of the Novo Nordisk Foundation, Novo Holdings is committed to providing long-term capital to drive progress in healthcare and life sciences. The company invests in various life science sectors, including biotechnology, pharmaceuticals, and medical devices, and actively collaborates with its portfolio companies to help them maximize their potential and create value.
News & Signals (0)
No linked news activity found for this company.
Investor Listings
No investor listings assigned to this company yet.